Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway

Hongwei Mo, Han Su, Zhenyu Zhuang, Junjie Guan, Xuwei Zhang, Deshu Chen, Runze Guo, Xiangzhou Chen, Bin Zhou, Liheng Chen, Chongbin Zhong, Pingzhen Yang

Open source

DOI: 10.1016/j.ejphar.2026.179252
Published: 2026-10
Container: European Journal of Pharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179252,
  title = {Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway},
  author = {Hongwei Mo and Han Su and Zhenyu Zhuang and Junjie Guan and Xuwei Zhang and Deshu Chen and Runze Guo and Xiangzhou Chen and Bin Zhou and Liheng Chen and Chongbin Zhong and Pingzhen Yang},
  year = {2026},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2026.179252},
  url = {https://doi.org/10.1016/j.ejphar.2026.179252}
}

RIS

TY  - JOUR
TI  - Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway
AU  - Hongwei Mo
AU  - Han Su
AU  - Zhenyu Zhuang
AU  - Junjie Guan
AU  - Xuwei Zhang
AU  - Deshu Chen
AU  - Runze Guo
AU  - Xiangzhou Chen
AU  - Bin Zhou
AU  - Liheng Chen
AU  - Chongbin Zhong
AU  - Pingzhen Yang
PY  - 2026
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2026.179252
UR  - https://doi.org/10.1016/j.ejphar.2026.179252
ER  -

APA

Mo, H., Su, H., Zhuang, Z., Guan, J., Zhang, X., Chen, D., Guo, R., Chen, X., Zhou, B., Chen, L., Zhong, C., & Yang, P. (2026). Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.179252

Source records

crossref · retrieved 2026-09-25T19:26:14.013Z